Brief: Epigenomics Appoints Andrew Lukowiak As President And Chief Scientific Officer
18/11/2021 07:07
Nov 18 (Reuters) - EPIGENOMICS AG ECXn.DE :
* SUPERVISORY BOARD OF EPIGENOMICS AG APPOINTS DR.
ANDREW
LUKOWIAK AS PRESIDENT AND CHIEF SCIENTIFIC OFFICER
* NEW PRESIDENT AND CHIEF SCIENTIFIC OFFICER TO JOIN
EPIGENOMICS
ON DECEMBER 1, 2021
* DR. LUKOWIAK, WHO HAS HELD SENIOR MANAGEMENT POSITIONS IN
U.S.
MOLECULAR DIAGNOSTICS INDUSTRY, WILL BECOME A MEMBER OF
EXECUTIVE BOARD OF EPIGENOMICS AND OVERSEE RESEARCH AND
DEVELOPMENT AND OPERATIONS
Source text for Eikon: ID:nEQ5pYN98a
Further company coverage: ECXn.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns